WoodJR, MillerKM, MaahsDM, et al.Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care, 2013; 36: 2035–2037.
2.
ForlenzaGP, PyleLL, MaahsDM, DunnTC. Ambulatory glucose profile analysis of the juvenile diabetes research foundation continuous glucose monitoring dataset – applications to the pediatric diabetes population. Pediatr Diabetes, 2016. doi: 10.1111/pedi.12474 [Epub ahead of print].
3.
BuckinghamBA, CameronF, CalhounP, MaahsDM, WilsonDM, ChaseHP, BequetteBW, LumJ, SibayanJ, BeckRW, KollmanC. Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia. Diabetes Technol Ther, 2013; 15: 622–627.
4.
BuckinghamBA, RaghinaruD, CameronF, BequetteBW, ChaseHP, MaahsDM, SloverR, WadwaRP, WilsonDM, LyT, AyeT, Hramiak, ClarsonC, SteinR, GallegoPH, LumJ, SibayanJ, KollmanC, BeckRW; In Home Closed Loop Study Group. Predictive low-glucose insulin suspension reduces duration of nocturnal hypoglycemia in children without increasing ketosis. Diabetes Care, 2015; 38: 1197–1204.
5.
BiesterT, KordonouriO, HolderM, RemusK, Kieninger-BaumD, WadienT, DanneT. “Let the algorithm do the work”: reduction of hypoglycemia using sensor-augmented pump therapy with predictive insulin suspension (SmartGuard) in pediatric type 1 diabetes patients. Diabetes Technol Ther, 2017; 19: 173–182.
6.
TsalikianE, MaurasN, BeckRW, et al.Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr, 2005; 147: 528–534.
7.
DuBoseSN, HermannJM, TamborlaneWV, BeckRW, DostA, DiMeglioLA, SchwabKO, HollRW, HoferSE, MaahsDM; Type 1 Diabetes Exchange Clinic Network and Diabetes Prospective Follow-up Registry. Obesity in youth with type 1 diabetes in Germany, Austria, and the United States. J Pediatr, 2015; 167: 627–32.e1–4.
DovčK, BratinaN, BattelinoT. A new horizon for glucose monitoring. Horm Res Paediatr, 2015; 83: 149–156.
10.
RachmielM, LandauZ, BoazM, et al.The use of continuous glucose monitoring systems in a pediatric population with type 1 diabetes mellitus in real-life settings: the AWeSoMe study group experience. Acta Diabetol, 2015; 52: 323–329.
11.
T1D Exchange Clinic Network. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. Diabetes Care, 2014; 37: 2702–2709.
12.
RodbardD. Continuous glucose monitoring: a review of success, challenges, and opportunities. Diabetes Technol Ther, 2016; 18 (Suppl 2): 3–13.
13.
ÓlafsdóttirAF, AttvallS, SandgrenU, DahlqvistS, PivodicA, SkrticS, TheodorssonE, LindM. A clinical trial of the accuracy and treatment experience of the flash glucose monitor FreeStyle Libre in adults with type 1 diabetes. Diabetes Technol Ther, 2017; 19: 164–172.
14.
DanneT, BattelinoT, Jarosz-ChobotP, et al.; PedPump Study Group. Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries. Diabetologia, 2008; 51: 1594–1601.
15.
MatykaKA, CrowneEC, HavelPJ, MacdonaldIA, MatthewsD, DungerDB. Counter regulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes. Diabetes Care, 1999; 22: 1144–1150.
